With the fall and winter season approaching comes the risk of the seasonal flu, respiratory syncytial virus (RSV), and COVID-19 making for a possible tripledemi
Researchers have now found several immune and hormonal differences in the blood of long covid patients, which could help them develop an accurate test for it.
Ensitrelvir (code name S-217622, brand name Xocova), is a new inhibitor of the SARS-CoV-2 major protease (Mpro), also known as 3C-like protease, has been shown to reduce the viral load and help alleviate the severity of SARS-CoV-2 in infected hamsters. In cells, low nanomolar to sub-micromolar doses of Ensitrelvir suppress viral growth.
LA JOLLA, CA AbbVie (NYSE: ABBV) and Scripps Research, an independent, non-profit biomedical research and drug discovery institute, today announced a global collaboration to develop potential novel, direct-acting antiviral treatments for COVID-19.